A citation-based method for searching scientific literature


List of co-cited articles
1166 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
39

Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Lincoln R Potter, Andrea R Yoder, Darcy R Flora, Laura K Antos, Deborah M Dickey. Handb Exp Pharmacol 2009
310
23


Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.
Ondrej Lisy, Brenda K Huntley, Daniel J McCormick, Paul A Kurlansky, John C Burnett. J Am Coll Cardiol 2008
126
21


Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Milton Packer, John J V McMurray, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. Circulation 2015
397
20

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
932
19


Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects.
Candace Y W Lee, Horng H Chen, Ondrej Lisy, Suzanne Swan, Courtney Cannon, Hsiao D Lieu, John C Burnett. J Clin Pharmacol 2009
77
24

A new natriuretic peptide in porcine brain.
T Sudoh, K Kangawa, N Minamino, H Matsuo. Nature 1988
18


Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Milton Packer, Robert M Califf, Marvin A Konstam, Henry Krum, John J McMurray, Jean-Lucien Rouleau, Karl Swedberg. Circulation 2002
450
18

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Scott D Solomon, Michael Zile, Burkert Pieske, Adriaan Voors, Amil Shah, Elisabeth Kraigher-Krainer, Victor Shi, Toni Bransford, Madoka Takeuchi, Jianjian Gong,[...]. Lancet 2012
677
18

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.
S Suga, K Nakao, K Hosoda, M Mukoyama, Y Ogawa, G Shirakami, H Arai, Y Saito, Y Kambayashi, K Inouye. Endocrinology 1992
652
17

Furin-mediated processing of Pro-C-type natriuretic peptide.
Chengliang Wu, Faye Wu, Junliang Pan, John Morser, Qingyu Wu. J Biol Chem 2003
141
17

Bioactivity and metabolism of C-type natriuretic peptide in normal man.
P J Hunt, A M Richards, E A Espiner, M G Nicholls, T G Yandle. J Clin Endocrinol Metab 1994
142
17

Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).
Jessie Gu, Adele Noe, Priya Chandra, Suliman Al-Fayoumi, Monica Ligueros-Saylan, Ramesh Sarangapani, Suzanne Maahs, Gary Ksander, Dean F Rigel, Arco Y Jeng,[...]. J Clin Pharmacol 2010
299
17



Evidence for functional heterogeneity of circulating B-type natriuretic peptide.
Faquan Liang, Jessica O'Rear, Ute Schellenberger, Lungkuo Tai, Michael Lasecki, George F Schreiner, Fred S Apple, Alan S Maisel, N Stephen Pollitt, Andrew A Protter. J Am Coll Cardiol 2007
209
15

Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.
Takeshi Horio, Takeshi Tokudome, Toshiyuki Maki, Fumiki Yoshihara, Shin-Ichi Suga, Toshio Nishikimi, Masayasu Kojima, Yuhei Kawano, Kenji Kangawa. Endocrinology 2003
132
15

Effect of nesiritide in patients with acute decompensated heart failure.
C M O'Connor, R C Starling, A F Hernandez, P W Armstrong, K Dickstein, V Hasselblad, G M Heizer, M Komajda, B M Massie, J J V McMurray,[...]. N Engl J Med 2011
823
15


Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure.
Adam M Hawkridge, Denise M Heublein, H Robert Bergen, Alessandro Cataliotti, John C Burnett, David C Muddiman. Proc Natl Acad Sci U S A 2005
216
14

Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.
Christopher Newton-Cheh, Martin G Larson, Ramachandran S Vasan, Daniel Levy, Kenneth D Bloch, Aarti Surti, Candace Guiducci, Sekar Kathiresan, Emelia J Benjamin, Joachim Struck,[...]. Nat Genet 2009
301
14

C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
Takeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, Takeshi Tokudome, Takeshi Horio, Kenji Mori, Kenji Kangawa. J Am Coll Cardiol 2005
129
14

Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma.
A J Stingo, A L Clavell, D M Heublein, C M Wei, M R Pittelkow, J C Burnett. Am J Physiol 1992
236
14


Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.
John B Kostis, Milton Packer, Henry R Black, Roland Schmieder, David Henry, Elliott Levy. Am J Hypertens 2004
354
14

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.
Sarah Mangiafico, Lisa C Costello-Boerrigter, Ingrid A Andersen, Alessandro Cataliotti, John C Burnett. Eur Heart J 2013
157
14

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
13

Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep.
C J Charles, E A Espiner, M G Nicholls, A M Richards, T G Yandle, A Protter, T Kosoglou. Am J Physiol 1996
85
15

Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
Eric E Niederkofler, Urban A Kiernan, Jessica O'Rear, Santosh Menon, Syed Saghir, Andrew A Protter, Randall W Nelson, Ute Schellenberger. Circ Heart Fail 2008
132
13

Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure.
Wayne L Miller, Mary A Phelps, Christina M Wood, Ute Schellenberger, Anh Van Le, Regis Perichon, Allan S Jaffe. Circ Heart Fail 2011
85
15

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
N Matsukawa, W J Grzesik, N Takahashi, K N Pandey, S Pang, M Yamauchi, O Smithies. Proc Natl Acad Sci U S A 1999
308
12

Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.
Naohisa Tamura, Lynda K Doolittle, Robert E Hammer, John M Shelton, James A Richardson, David L Garbers. Proc Natl Acad Sci U S A 2004
201
12

Dwarfism and early death in mice lacking C-type natriuretic peptide.
H Chusho, N Tamura, Y Ogawa, A Yasoda, M Suda, T Miyazawa, K Nakamura, K Nakao, T Kurihara, Y Komatsu,[...]. Proc Natl Acad Sci U S A 2001
328
12

Physiological role of silent receptors of atrial natriuretic factor.
T Maack, M Suzuki, F A Almeida, D Nussenzveig, R M Scarborough, G A McEnroe, J A Lewicki. Science 1987
12


Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide.
Kristin Pankow, Yong Wang, Florian Gembardt, Eberhard Krause, Xiaoou Sun, Gerd Krause, Heinz-Peter Schultheiss, Wolf-Eberhard Siems, Thomas Walther. Circ Res 2007
52
23

Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase.
M W Smith, E A Espiner, T G Yandle, C J Charles, A M Richards. J Endocrinol 2000
79
15

Human B-type natriuretic peptide is not degraded by meprin A.
Deborah M Dickey, Lincoln R Potter. Biochem Pharmacol 2010
23
52

The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide.
S Jeson Sangaralingham, Brenda K Huntley, Fernando L Martin, Paul M McKie, Diego Bellavia, Tomoko Ichiki, Gerald E Harders, Horng H Chen, John C Burnett. Hypertension 2011
72
16

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
J L Rouleau, M A Pfeffer, D J Stewart, D Isaac, F Sestier, E K Kerut, C B Porter, G Proulx, C Qian, A J Block. Lancet 2000
317
12



Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure.
Nicolas Vodovar, Marie-France Séronde, Said Laribi, Etienne Gayat, Johan Lassus, Riadh Boukef, Semir Nouira, Philippe Manivet, Jane-Lise Samuel, Damien Logeart,[...]. Eur Heart J 2014
72
16

Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.
Antoni Bayés-Genís, Jaume Barallat, Amparo Galán, Marta de Antonio, Mar Domingo, Elisabet Zamora, Agustín Urrutia, Josep Lupón. J Am Coll Cardiol 2015
102
12


Effects of synthetic atrial natriuretic factor on renal function and renin release.
J C Burnett, J P Granger, T J Opgenorth. Am J Physiol 1984
734
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.